A novel coronavirus outbreak of global health concern
By Chen Wang, P. Horby, F. Hayden, George F. Gao. The Lancet, 2020
6,733 citations recorded by the source corpus.
470 www.thelancet.com Vol 395 February 15, 2020 In December, 2019, Wuhan, Hubei province, China, became the centre of an outbreak of pneumonia of unknown cause, which raised intense attention not only within China but internationally. Chinese health authorities did an immediate investigation to characterise and control the disease, including isolation of people suspected to have the disease, close monitoring of contacts, epidemiological and clinical data collection from patients, and development of diagnostic and treatment procedures. By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus (CoV) from patients in Wuhan. The genetic sequence of the 2019 novel coronavirus (2019-nCoV) enabled the rapid development of point-of-care real-time RT-PCR diagnostic tests specific for 2019-nCoV (based on full genome sequence data on the Global Initiative on Sharing All Influenza Data [GISAID] platform). Cases of 2019-nCoV are no longer limited to Wuhan. Nine exported cases of 2019-nCoV infection have been reported in Thailand, Japan, Korea, the USA, Vietnam, and Singapore to date, and further dissemination through air travel is likely. As of Jan 23, 2020, confirmed cases were consecutively reported in 32 provinces, municipalities, and special administrative regions in China, including Hong Kong, Macau, and Taiwan. These cases detected outside Wuhan, together with the detection of infection in at least one household cluster— reported by Jasper Fuk-Woo Chan and colleagues in The Lancet—and the recently documented infections in health-care workers caring for patients with 2019-nCoV indicate human-to-human transmission and thus the risk of much wider spread of the disease. As of A novel coronavirus outbreak of global health concern by genetic sequencing as a novel coronavirus. Risk assessment at that time was guarded but suggested that the outbreak was more like that caused by the Middle East respiratory syndrome (MERS) coronavirus than the severe acute respiratory syndrome (SARS) coronavirus. However, this information was from what now appears to be first-generation cases from a point source, but at the time it seems that a second generation, and perhaps a third generation, of cases was already reported in the incubation period, and this generation appears to have included health workers. Health worker infections are an ominous finding in any emerging infection. Front-line health workers can be initially at risk and infected when they examine and treat patients who present with a respiratory infection; if handwashing or other infection prevention and control measures are not in place, these health workers are at great risk of infection and become the inadvertent carriers to patients who are in hospital for other diseases and treatments, family members, and the community. Early in the SARS coronavirus outbreak, frontline health workers became infected, which amplified transmission to patients in hospitals where outbreaks were occurring. Early evidence from the initial MERS outbreaks suggested that health workers were likewise being infected, but that their infections were less severe than those of patients in hospitals who became infected and had comorbidities such as diabetes or chronic respiratory disease. Today, the epidemiology of both SARS and MERS viruses is mostly understood, and the same will be true for the current outbreak of 2019-nCoV if data continue to be freely shared and used to provide realtime guidance. These Articles and others being rapidly disseminated and shared will have a major role in assuring that this global collaboration occurs.
Subfields: Infectious Diseases, Modeling and Simulation
View Paper: https://www.semanticscholar.org/paper/3261c2974156a5446a61332c9f9023c07422ae44
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
- Hannah Kleine-Weber
- W. Ling
- China Cdc Weekly
- S. Pöhlmann
- Christian Drosten
- M. Hoffmann
- David Gurwitz
- L. Garcia
In Modeling and Simulation
Citations in the corpus
- Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients (2020, background): “…whose expression is required by several viruses (Deffrasnes et al., 2016) ( Figure A Single-Cell Map of SARS-CoV-2 Infection in Mild and Severe Patients COVID-19 is a viral disease caused by SARS-CoV-2 infection, which has recently been recognized as the cause for a pandemic (Wang et al., 2020a).”
- Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach (2020, background): “Remdesivir, a nucleotide analogue has presented antiviral activity (EC 50 ¼ 0.77 l M) against SARS-Cov-2 (Wang et al., 2020).”
- COVID-19 outbreak: Migration, effects on society, global environment and prevention (2020, neutral): “Live animals like bat, frog, snake, bird, marmot and rabbit are frequently sold at the Hunan seafood market (Wang et al., 2020b) .”
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV (2020, background): “7:1 [38] and the aver ge incubation period is 5.”
- Explainable Deep Learning for Pulmonary Disease and Coronavirus COVID-19 Detection from X-rays (2020, neutral): “In details, the current research lines are related to the COVID-19 detection from medical images [5,36,37] (this is direction of the method we propose) and to protein analysis to boost research in COVID-19 vaccines [38,39] .”
- Can we contain the COVID-19 outbreak with the same measures as for SARS? (2020, neutral): “30 China has higher medical standards, a better educated healthcare workforce, and more technical and scientific expertise now than in 2003.”
- Structure analysis of the receptor binding of 2019-nCoV (2020, background): “We know that the virus is capable of spreading quickly from human to human and that people can spread the virus even before they become symptomatic [1].”
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells (2020, neutral): “It is believed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously termed nCoV-2019) was introduced into the human population from a poorly characterized animal reservoir in late 2019 (Ge et al., 2013; Wang et al., 2020; Zhou et al., 2020b; Zhu et al., 2020).”
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State (2020, neutral): “5) [20] 28 (26-30) [17] 31 (NA) [1]d 25 (21-26) [7]”
- C-reactive protein levels in the early stage of COVID-19 (2020, background): “[6] Wang C, Horby PW, Hayden FG, Gao GF.”